Xaluprine 20mg/ml oral suspension (mercaptopurine monohydrate): interim supply of Ireland stock to mitigate supply disruption

Following supply disruption, Nova has obtained MHRA approval to supply product intended for Ireland (batch number 1230Pj101; batch size 85 packs) to ensure continuity of supply. Product expected to be on market till Dec 2021. There are minor differences in Irish & UK product info

Nova Laboratories Ltd